Search

everythinglearnresearchcommunity

for

Search:↓

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Immune system changes may contribute to female pattern hair loss.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

ANp63 is crucial for skin integrity, new filaggrin gene mutations link to eczema, hair can regrow from non-stem cells, sunburns are increasing, and glucocorticoids help treat skin allergies by affecting immune cells.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Abnormal ECM and immune cell interactions can cause skin diseases.

Genetic differences affect COVID-19 severity and treatment development.

Asthma may increase the risk of alopecia areata.

Goat genes show adaptation to environments and traits like body development, with differences among cashmere, feral, and milk-producing goats.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

MEG3-miRNAs help control wool traits in young Tan sheep by regulating immune responses, but their decline with age leads to wool changes.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Skin fat has important roles in hair growth, skin repair, immune defense, and aging, and could be targeted for skin and hair treatments.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Disruptions in epidermal polarity genes can lead to skin diseases.

Genes affect cytokine production, which can influence chronic diseases, and certain interventions may help prevent related molecular damage.

Histocultures help personalize cancer treatments, study hair growth, and explore immune responses.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

A gene-based model predicts lung adenocarcinoma outcomes and helps guide treatment decisions.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Genetic differences affect how people respond to COVID-19.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

A new genetic mutation in the CAST gene may link PLACK syndrome to alopecia areata.